5-Methyl-5, 6-dihydrouridine 24-acid FDA Approves Qinlock (ripretinib) for

FDA Approves Qinlock (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

Smiles: CCOC1=CC2C=CC(=CC=2C=C1)C1=CC(=CN=C1N)C1=CC(=CC=C1)C(=O)NCCN(C)C

The oral Berbamine treatment greatly suppresses the growth of Huh7 xenografted tumors over the time and leads to a tumor reduction by 70% based on the tumor weight

Smiles: CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1C=CC(=CC=1)/C(/N)=N/O

5-Methyl-5, 6-dihydrouridine 24-acid FDA Approves Qinlock (ripretinib) for5 Methyl 5,6 dihydrouridine is a minor constituent in the chromosomal RNA of the rat ascites tumor. 5 Methyl 5,6 dihydrouridine can be used for nucleic acid modification. Product information CAS Number: 23067 10 9 Molecular Weight: 260. 24 Formula: C10H16N2O6 Chemical Name: 1 [(2R,3R,4S,5R) 3,4 dihydroxy 5 (hydroxymethyl)oxolan 2 yl] 5 methyl 1,3 diazinane 2,4 dione Smiles: CC1CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)NC1=O InChiKey: BTFXIEGOSDSOGN